Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats

Journal of Endocrinology

Volumn 185, Issue 3, 2005, Pages 467-476

  Priego, Teresa ^a   Granado, Miriam ^a   Martín, Ana Isabel ^b   López Calderón, Asunción ^a   Villanúa, María Angeles ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GROWTH HORMONE RECEPTOR; LIPOPOLYSACCHARIDE; MESSENGER RNA; SODIUM CHLORIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; ENZYME INHIBITION; GENE EXPRESSION; HORMONE INHIBITION; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANIMALS; BACTERIAL INFECTIONS; BLOTTING, NORTHERN; BLOTTING, WESTERN; DEXAMETHASONE; GENE EXPRESSION; GLUCOCORTICOIDS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; NITRATES; NITRITES; RATS; RATS, WISTAR; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER;

EID: 21244444242     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06109     Document Type: Article

References (40)

1. Albiston AL & Herington AC 1990 Cloning and characterization of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat. Biochemical and Biophysical Research Communications 166 892-897.
2. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P & Bellissant E 2002 Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Journal of the American Medical Association 288 862-871.
3. Bang P, Degerblad M, Thoren M, Schwander J, Blum W & Hall K 1993 Insulin-like growth factor (IGF)-I and -II and IGF binding protein (IGFBP)-1, -2 and -3 in serum from patients with Cushing's syndrome. Acta Endocrinologica 128 397-404.
4. Baumbach WR, Horner DL & Logan JS 1989 The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes and Development 3 1199-1205.
5. Beauloye V, Ketelslegers JM, Moreau B & Thissen JP 1999 Dexamethasone inhibits both growth hormone (GH)-induction of insulin-like growth facror-I (IGF-I) mRNA and GH receptor (GHR) mRNA levels in rat primary cultured hepatocytes. Growth Hormone and IGF Research 9 205-211.
6. Blat C, Villaudy J & Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Journal of Clinical Investigation 93 2286-2290.
7. Canalis E 1997 Insulin-like growth factors and osteoporosis. Bone 21 215-216.
8. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE & Clemmons DR 1992 Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. Journal of Clinical Endocrinology and Metabolism 75 590-595.
9. De Mellow JSM & Baxter RC 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochemical and Biophysical Research Communications 156 199-204.
10. Fan J, Molina PE, Gelato MC & Lang CH 1994 Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134 1685-1692.
11. Gabrielsson BG, Carmignac DF, Flavell DM & Robinson ICAF 1995 Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology 136 209-217.
12. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL & Billiar TR 1993 Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. PNAS 90 522-526.
13. Gronbek H, Thogersen T, Frystyk J, Vilstrup H, Flyvbjerg A & Dahlerup JE 2002 Low free and total insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. American Journal of Gastroenterology 97 673-678.
14. Heinrichs C, Yanovski JA, Roth AH, Yu YM, Domené HM, Yano K, Cutler GB & Baron J 1994 Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate. Endocrinology 135 1113-1118.
15. Ibáñez de Cáceres I, Holly JMP, Priego T, Martín AI, López-Calderón A & Villanúa MA 2002a Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity. Journal of Endocrinology 173 357-364.
16. Ibáñez de Cáceres I, Priego T, Martín AI, López-Calderón A & Villanúa MA 2002b GH administration and renal IGF-I system in arthritic rats. Life Sciences 71 139-151.
17. Ibáñez de Cáceres I, Priego T, Martín AI, Granado M, López-Calderón A & Villanúa MA 2003 Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats. European Journal of Pharmacology 481 293-299.
18. Koedam JA, Hoogerbrugge CM & Van Buul-Offers SC 2000 Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone. Journal of Endocrinology 165 557-567.
19. Kritsch KR, Murali S, Adamo ML & Ney DM 2002 Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 282 R528-R536.
20. Lamson G, Giudice LC & Rosenfeld RG 1991 A simple assay for the proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3). Clinical Endocrinology and Metabolism 72 1391-1393.
21. Lang CH, Pollard V, Fan J, Traber L, Traber DL, Frost RA, Gelato MC & Prough DS 1997 Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 273 R371-R378.
22. Li YH, Fan J & Lang CH 1997 Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 272 R1990-R1997.
23. López-Calderón A, Ibáñez de Cáceres I, Soto L, Priego T, Martín AI & Villanúa MA 2001 The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA. European Journal of Endocrinology 144 1-6.
24. Luo JM & Murphy LJ 1989 Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in intact rats. Endocrinology 125 165-171.
25. Luo JM & Murphy LJ 1990 Regulation of insulin-like growth factor binding protein-3 expression by dexamethasone. Molecular and Cellular Endocrinology 74 213-219.
26. Miell JP, Buchanan CR, Norman MR, Maheshwari HG & Blum WF 1994 The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH) and GH-binding protein as a result of short-term dexamethasone treatment. Journal of Endocrinology 142 547-554.
27. Miranda KM, Espey MG & Wink DA 2001 A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 62-71.
28. Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA & López-Calderón A 2002a Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA. Journal of Endocrinology 172 449-456.
29. Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA & López-Calderón A 2002b Hepatic insulin-like growth factor-I binding protein 3 gene expression in rats with endotoxic shock: the role of glucocorticoids. Annals of the New York Academy of Sciences 973 88-90.
30. Priego T, Granado M, Ibáñez de Cáceres I, Martín AI, Villanúa MA & López-Calderón A 2003a Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. Journal of Endocrinology 179 107-117.
31. Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA & López-Calderón A 2003b Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats. Molecular and Cellular Endocrinology 199 23-28.
32. Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA & López-Calderón A 2004 NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver. American Journal of Physiology - Endocrinology and Metabolism 286 E50-E56.
33. Roberts CT, Lasky SR, Lowe WL, Seaman WT & LeRoith D 1987 Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extra hepatic tissues. Molecular Endocrinology 1 243-248.
34. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Janssen JO & Ohlsson C 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. PNAS 96 7088-7092.
35. Soto L, Martín AI, Millán S, Vara E & López-Calderón A 1998 Effects of endotoxin lipopolysaccharide administration on the somatotropic axis. Journal of Endocrinology 159 239-246.
36. Stoving RK, Flyvbjerg A, Frystyk J, Fisker S, Hangaard J, Hasen-Nord M & Hagen C 1999 Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis. Journal of Clinical Endocrinology and Metabolism 84 1346-1350.
37. Trachtman H, Futterweit S, Garg P, Reddy K & Singhal PC 1996 Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochemical and Biophysical Research Communications 218 704-708.
38. Villafuerte BC, Koop BL, Pao CI & Phillips LS 1995 Glucocorticoid regulation of insulin-like growth factor-binding protein-3. Endocrinology 136 1928-1933.
39. Ward WE, Atkinson SA, Donovan SM & Paes B 1999 Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants. Early Human Development 56 127-141.
40. Yildiz O, Doganay M, Aygen B, Guven M, Keleutimur F & Tutuu A 2002 Physiological-dose steroid therapy in sepsis. Critical Care 6 251-258.